Sumitomo Pharma America loosened or ended its 340B contract pharmacy restrictions in an additional five states.

Sumitomo Loosens 340B Contract Pharmacy Restrictions in Five More States

Drugmaker Sumitomo Pharma America (SMPA) is partially or fully exempting providers in five additional states from its 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.